Abstract
Erythrodermic psoriasis (EP) in pediatrics is a rare case. Adherence to the psoriasis vulgaris treatment is important to prevent progression to erythroderma. Systemic infection is also one of the triggers of EP. Here we present a boy with erythrodermic psoriasis that was successfully treated with cyclosporine.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Fraga N, Paim M, Follador I, Rego VR, Ramos A. Refractory erythrodermic psoriasis in a child with an excellent outcome by using etarnecept. An Bras Dermatol. 2011;86:144–7.
Singh RK, Lee KM, Ucmak D, Brodsky M, Atanelov Z, Farahnik B, et al. Erythrodermic psoriasis: pathophysiology and current treatment perspectives. Psoriasis Targets Ther. 2016;6:93–104.
Pinson R, Sotoodian B, Fiorillo L. Psoriasis in children. Psoriasis Targets Ther. 2016;6:121–9.
Dogra S, Bishnoi A. Childhood psoriasis: What is new and what is news. Indian J Paediatr Dermatol. 2018;19:308–14.
Napolitano M, Megna M, Balato A, Ayala F, Lembo S, Villani A, et al. Systemic treatment of pediatric psoriasis: a review. Dermatol Ther (Heidelb). 2016;6(2):125–42.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Diba, S., Husan, N., Octyvani, T.M. (2022). Erythrodermic Psoriasis in Pediatric Age. In: Lotti, T.M., Arcangeli, F. (eds) Clinical Cases in Adolescent Dermatology. Clinical Cases in Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-030-91526-1_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-91526-1_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-91525-4
Online ISBN: 978-3-030-91526-1
eBook Packages: MedicineMedicine (R0)